T3 Companies, LLC

Position in CLDX — Celldex Therapeutics, Inc.

CIK 2052441 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$223,260

New position

Shares Held

6,000

first reported quarter

Ownership

0.008%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

#19

of 41 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names. CLDX ranks #4 (8.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	7,815	$1,041,426
2	IFRX	InflaRx N.V.	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc.	945,000	$615,195
4	CLDX	Celldex Therapeutics, Inc. This page	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$223,260	6,000	—	Shares	Sole	2026-07-27
No filing history on record for this holder in this stock.